Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 Inhibitors-Reference-Cited by-同舟云学术

Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 Inhibitors

Published:2006-08-02 Issue:15 Volume:98 Page:1068-1077
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Gyurkocza Boglarka,Plescia Janet,Raskett Christopher M.,Garlick David S.,Lowry Philip A.,Carter Bing Z.,Andreeff Michael,Meli Massimiliano,Colombo Giorgio,Altieri Dario C.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/98/15/1068/7687450/djj300.pdf

Reference50 articles.

1. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science2002 ; 295 : 1852 –8.

2. Pearl LH, Prodromou C. Structure and in vivo function of Hsp90. Curr Opin Struct Biol2000 ; 10 : 46 –51.

3. Young JC, Moarefi I, Hartl FU. Hsp90: a specialized but essential protein-folding tool. J Cell Biol2001 ; 154 : 267 –73.

4. Schmid D, Baici H, Gehring H, Christen P. Kinetics of molecular chaperon action. Science1994 ; 263 : 971 –3.

5. Neckers L, Ivy SP. Heat shock protein 90. Curr Opin Oncol2003 ; 15 : 419 –24.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin (BIRC5): Implications in cancer therapy;Life Sciences;2024-08

2. Current and future prospective of caspases targeting in cancer therapy;Caspases as Molecular Targets for Cancer Therapy;2024

3. Theaflavin-3-gallate, a natural antagonist for Hsp90: In-silico and in-vitro approach;Chemico-Biological Interactions;2022-02

4. A novel mode of action for COX‐2 inhibition: Targeting ATPase domain of HSP90 induces ubiquitin degradation of new client protein COX‐2;Clinical and Translational Medicine;2022-01

5. Cell-Impermeable Peptide Fragments of Survivin and Hsp70/Hsp90-Organizing Protein Inhibit the Hsp90-Dependent Migration and Invasion of Tumor Cells;Biophysics;2021-09